Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PARA
2526
DELISTED
Paramount Global Class B
PARA
| $14.1M | ﹤0.01% |
1,350,513
+830,706
| +160% | +$8.93M |
|
|
WAY
2527
Waystar Holding Corp
WAY
$4.75B
| $14.1M | ﹤0.01% |
383,956
+78,618
| +26% | +$2.42M |
|
2528
PUT
Root
ROOT
$797M
| $14.1M | ﹤0.01% |
194,100
+45,300
| +30% | +$3.13M |
|
2529
Korro Bio
KRRO
$196M
| $14.1M | ﹤0.01% |
369,733
-159,440
| -30% | -$8.19M |
|
2530
Shoals Technologies Group
SHLS
$1.42B
| $14.1M | ﹤0.01% |
2,544,342
+2,400,262
| +1,666% | +$12.2M |
|
|
BBOT
2531
BridgeBio Oncology
BBOT
$726M
| $14.1M | ﹤0.01% |
1,339,670
+7,020
| +0.5% | +$73.9K |
|
2532
CALL
Box
BOX
$4.52B
| $14.1M | ﹤0.01% |
444,700
+198,600
| +81% | +$6.51M |
|
2533
CALL
Shift4
FOUR
$3.58B
| $14.1M | ﹤0.01% |
135,400
-26,200
| -16% | -$2.6M |
|
2534
ONE Gas
OGS
$5.09B
| $14M | ﹤0.01% |
202,245
+12,758
| +7% | +$931K |
|
2535
PUT
Blue Owl Capital
OWL
$19.1B
| $14M | ﹤0.01% |
601,700
+338,300
| +128% | +$7.74M |
|
2536
Cabot Corp
CBT
$4.54B
| $14M | ﹤0.01% |
153,238
-30,604
| -17% | -$3.29M |
|
2537
CALL
Ollie's Bargain Outlet
OLLI
$4.62B
| $14M | ﹤0.01% |
127,400
+30,000
| +31% | +$2.99M |
|
2538
Navios Maritime Partners
NMM
$2.33B
| $14M | ﹤0.01% |
322,737
+39,937
| +14% | +$2.09M |
|
2539
PUT
SentinelOne
S
$7.92B
| $13.9M | ﹤0.01% |
628,200
+77,800
| +14% | +$1.99M |
|
2540
PUT
PBF Energy
PBF
$8.52B
| $13.9M | ﹤0.01% |
524,800
+114,000
| +28% | +$3.47M |
|
2541
Simply Good Foods
SMPL
$1B
| $13.9M | ﹤0.01% |
357,235
+284,561
| +392% | +$10.4M |
|
2542
Capital Group Core Plus Income ETF
CGCP
$8.51B
| $13.9M | ﹤0.01% |
624,142
+420,998
| +207% | +$9.5M |
|
2543
CALL
West Pharmaceutical
WST
$24.6B
| $13.8M | ﹤0.01% |
42,200
-6,000
| -12% | -$1.89M |
|
2544
Darden Restaurants
DRI
$25.6B
| $13.8M | ﹤0.01% |
73,956
-507,878
| -87% | -$85.2M |
|
2545
CALL
Zimmer Biomet
ZBH
$19.2B
| $13.8M | ﹤0.01% |
130,500
-2,100
| -2% | -$225K |
|
2546
PUT
TotalEnergies
TTE
$196B
| $13.8M | ﹤0.01% |
252,700
+90,400
| +56% | +$5.5M |
|
2547
iShares MSCI United Kingdom ETF
EWU
$4.13B
| $13.8M | ﹤0.01% |
405,936
+158,198
| +64% | +$5.63M |
|
2548
Cellebrite
CLBT
$2.79B
| $13.8M | ﹤0.01% |
624,479
-219,174
| -26% | -$4.22M |
|
2549
Vanguard Long-Term Bond ETF
BLV
$5.7B
| $13.7M | ﹤0.01% |
200,836
+124,447
| +163% | +$8.88M |
|
2550
PUT
Alnylam Pharmaceuticals
ALNY
$30.6B
| $13.7M | ﹤0.01% |
58,400
-76,800
| -57% | -$20.2M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.